Fujisawa-shi

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Chronic kidney disease4 trials
• Asthma1 trial
• Atrial fibrillation1 trial
• Chronic rhinosinusitis with nasal polyps1 trial
• Heart failure1 trial
• High blood pressure1 trial
• Ventricular tachycardia1 trial

Phase

• Phase 36 trials
• Phase 21 trial

Status

• Active, not recruiting2 trials
• Terminated2 trials
• Completed1 trial
• Not yet recruiting1 trial
• Recruiting1 trial

Lead sponsor

• AstraZeneca7 trials

Running trials

• Recruiting

  A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

  NCT07753993· Phase 3· AstraZeneca· Source

• Recruiting

  Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

  NCT06307652· Phase 3· AstraZeneca· Source

• Active, not recruiting

  A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.

  NCT06268873· Phase 3· AstraZeneca· Source

• Active, not recruiting

  Study to Investigate Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin in Participants With Chronic Kidney Disease and High Proteinuria (ZENITH High Proteinuria)

  NCT06087835· Phase 3· AstraZeneca· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Chronic kidney disease1 recruiting
• Heart failure1 recruiting

Closed trials

• Completed

  Efficacy, Safety and Tolerability of Balcinrenone/Dapagliflozin Compared to Dapagliflozin in Adults With Chronic Kidney Disease

  NCT06350123· Phase 2· AstraZeneca· Source

• Terminated

  Effect of Sodium Zirconium Cyclosilicate on Arrythmia-related Cardiovascular Outcomes in Participants on Chronic Hemodialysis With Recurrent Hyperkalemia (DIALIZE-Outcomes)

  NCT04847232· Phase 3· AstraZeneca· Source

• Terminated

  Efficacy and Safety Study of Benralizumab in Patient With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps (ORCHID)

  NCT04157335· Phase 3· AstraZeneca· Source